Clinical Trials Logo

Healthy Population clinical trials

View clinical trials related to Healthy Population.

Filter by:

NCT ID: NCT06314685 Active, not recruiting - Healthy Population Clinical Trials

Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years

Start date: December 10, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.

NCT ID: NCT06314659 Active, not recruiting - Healthy Population Clinical Trials

Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Start date: September 17, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the immunogenicity and safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 to 5 months old.

NCT ID: NCT05999916 Active, not recruiting - Clinical trials for Healthy Participants

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants

MindStim
Start date: December 27, 2023
Phase: N/A
Study type: Interventional

The present study aims to assess the safety and feasibility of repeated transcranial alternating current stimulation (tACS) by the Miamind Neurostimulator in a cohort of healthy participants. Based on the findings of this investigation, subsequent clinical trials assessing the efficiency of tACS by the Miamind Neurostimulator for treatment of Alzheimer's Disease will be conducted.

NCT ID: NCT05996042 Not yet recruiting - Healthy Population Clinical Trials

Time-restricted Diet Combined With Multimodal Aerobic Exercise

Start date: August 20, 2023
Phase: N/A
Study type: Interventional

Objective: This study aims to compare the effects of a combination of time-restricted diet and multimodal aerobic exercise (calisthenics, yoga, and comprehensive physical training) on cardiovascular and metabolic health in a sedentary population with both interventions alone. Study design. Randomized controlled trial Participants: Sedentary (average sitting time greater than 6 hours per day over the past six months, and average moderate-intensity physical activity less than 125 minutes per week or vigorous-intensity physical activity less than 75 minutes per week as assessed by the International Physical Activity Questionnaire). Sample size: 81 Study grouping and intervention measures: Subjects who signed informed consent and met the inclusion/exclusion conditions were randomly divided into the following three groups according to gender stratification, with 27 participants in each group: single time-limited diet group, single multi-mode aerobic exercise (aerobics, yoga and comprehensive physical training) group, and combination of time-limited diet and multi-mode aerobic exercise group. The subjects who received the time-restricted diet intervention were allowed to eat only from 7am to 3pm on Tuesdays, Thursdays and Saturdays, and were allowed to drink pure water only during the rest of the day. The subjects who received the multi-mode aerobic exercise intervention carried out the exercise intervention from 6:00 PM to 7:00 PM on Monday, Wednesday and Friday under the unified guidance of the physical education teacher of the Medical Department. All subjects did not limit their total daily energy intake. The intervention lasted eight weeks. Outcome evaluation indicators: The main indicators of this study were body composition (body fat, muscle mass, fat-free weight, body weight, BMI, body fat percentage, total body water, protein, inorganic salts, limb muscle and extracellular water ratio).

NCT ID: NCT05827198 Not yet recruiting - Clinical trials for Gastrointestinal Tolerance

Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies

Start date: September 12, 2023
Phase: N/A
Study type: Interventional

This study is a randomized, single-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of a sugar replacer blend (inulin + soluble corn fiber + erythritol) at 3 different doses

NCT ID: NCT05794100 Completed - Tolerance Clinical Trials

Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance

Start date: October 11, 2021
Phase: N/A
Study type: Interventional

This study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of 3 sugar replacers mixes at 3 different doses. The investigators will also try to understand the factors that could explain the presence or absence of symptoms

NCT ID: NCT05534477 Enrolling by invitation - Chronic Disease Clinical Trials

Verily Clinical Study Watch Analytical Validation Study

Start date: September 18, 2023
Phase:
Study type: Observational

This study is designed to evaluate the performance of the Verily Clinical Study Watch for the quantification of participants' movement and pulse rate when the wearer is at rest.

NCT ID: NCT05339841 Active, not recruiting - Healthy Population Clinical Trials

Italian Digital Primary Cardiovascular Prevention Study

CV-PREVITAL
Start date: June 10, 2022
Phase: N/A
Study type: Interventional

The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted by the Italian Network of Cardiology (ICN, a cardiovascular research network promoted by the Italian Ministry of Health), in collaboration with the Consorzio Sanità (Co.S., an Italian consortium of general practitioners), CV-PREVITAL aims to develop an innovative model of cardiovascular primary prevention and to validate it in a very large sample of subjects and in 'real life' conditions.

NCT ID: NCT05323032 Recruiting - Retinal Disease Clinical Trials

Multifocal Electroretinogram in Normal Egyptian Population

Start date: March 22, 2022
Phase: N/A
Study type: Interventional

Studying normal subjects to create unique normal database for multifocal electroretinogram (mf-ERG) in specific population.

NCT ID: NCT05193799 Completed - Healthy Population Clinical Trials

Evaluation of the Tolerance of Three Masks Under Dermatological Control.

Start date: January 3, 2022
Phase: N/A
Study type: Interventional

This is a monocentric, open and randomized study. The purpose is to evaluate the cutaneous tolerance of three medical masks (class I medical device) after 3 consecutive days of use on a population with normal or sensitive skin.